_
INM
InMed Pharmaceuticals Inc
Company Mission
InMed Pharmaceuticals Inc creates cannabinoid-based drugs for rare skin and eye disorders, such as epidermolysis bullosa. Doctors and patients use these treatments because they offer new options where few exist. The company makes money by partnering with other firms for research and aims to sell approved drugs in the future.
Industry Context
This company operates in the biotechnology sector, focusing on developing treatments using cannabinoids for rare diseases. It targets conditions like epidermolysis bullosa and glaucoma, where traditional options are limited. Revenue comes from collaborations and future drug commercialization, positioning it in a niche market with high unmet needs.
Scoring Terminal
Intelligence Pipeline Active
Technical Matrix
Momentum Engine
Social Frequency
ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.
Positive Catalysts
No active score modifiers detected
Risk Flags
Price is overextended from the 20-day trend lead.
Price is extended significantly above 52-week highs.
Banana Farmer tracks 100's of signals to synthesize this proprietary score.
Social Intelligence Pulse.
Our engine is currently indexing INM across global social channels to detect early sentiment shifts and technical alignment.
Signal Catalysts
Intelligence Narrative Connected
Educational only.
Loading chart...
Loading chart...
Loading chart...
Loading chart...